REFERENCES for introduction text
CERAMENT® G Instructions for Use.
REFERENCES for remodels into host bone within 6-12 months
Hofmann et al. ‘Autologous Iliac Bone Graft Compared with Biphasic Hydroxyapatite and Calcium Sulfate Cement for the
Treatment of Bone Defects in Tibial Plateau Fractures – A Prospective, Randomized, Open-Label, Multicenter Study.’J Bone Joint Surg Am. 2020;102:179-93.
Hettwer et al. ‘Establishment and effects of allograft and synthetic bone graft substitute treatment of a critical size metaphyseal bone defect model in the sheep femur’. APMIS 2019; 127:53–63.
Kaczmarczyk et al. ‘Complete twelve month bone remodeling with a bi-phasic injectable bone substitute in benign bone tumors: a prospective pilot study’. BMC Musculo. Dis. 2015;16:369.
REFERENCES for injectable and flowable
CERAMENT® G Instructions for Use.
Nilsson, M. ‘Injectable calcium sulphate and calcium phosphate bone substitutes’. Lund University. 2003. ISBN: 91-628-5603-0.
Hettwer et al. ‘Establishment and effects of allograft and synthetic bone graft substitute treatment of a critical size metaphyseal bone defect model in the sheep femur’. APMIS 2019; 127:53–63.
REFERENCES for gentamicin elution above MIC that is reliable and consistent
Stravinskas et al. ‘Pharmacokinetics of gentamicin eluted from a regenerating bone graft substitute – in vitro and clinical release studies’. Bone Joint Res. 2016;5:427-435.
Stravinskas et al. ‘Antibiotic containing bone substitute in major hip surgery: a long term gentamicin elution study’. J. Bone Joint Inf. 2018;3(2):68-72.
REFERENCES for high local concentration of gentamicin, without high serum gentamicin levels
Stravinskas et al. ‘Pharmacokinetics of gentamicin eluted from a regenerating bone graft substitute – in vitro and clinical release studies’. Bone Joint Res. 2016;5:427-435.
Colding-Rasmussen et al. ‘In-vivo and in-vitro evaluation of vancomycin and gentamicin elution from bone graft substitutes.’ European Bone and Joint Infection Society (EBJIS) 35th Annual Meeting, Oxford, September 2016.
Gentamicin 40mg/ml Solution for Injection or Infusion – Summary of Product Characteristics (SmPC) – (emc) (medicines.org.uk)